Early Allogeneic Hematopoietic Cell Transplantation in Treating Patients With Relapsed or Refractory High-Grade Myeloid Neoplasms
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Filgrastim
Related studies linked through entity extraction aliases.
Bendamustine and Rituximab Alternating With Cytarabine and Rituximab for Untreated Mantle Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Filgrastim, Cladribine, Cytarabine, and Mitoxantrone With Sorafenib in Treating Patients With Newly-Diagnosed, Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study to Evaluate the PK, Safety and Tolerability of GMI-1271 With and Without Filgrastim in Healthy Adult Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Sequential, Related Donor Partial Liver Transplantation Followed by Bone Marrow Transplantation for Hepatocellular Carcinoma (HCC)
- Status
- WITHDRAWN
- Phase
- PHASE2
Intermittent G-CSF in Patients With Breast Cancer Receiving Adjuvant Docetaxel, Doxorubicin, and Cyclophosphamide (TAC)
- Status
- TERMINATED
- Phase
- PHASE2
Liposome-encapsulated Daunorubicin-Cytarabine, Fludarabine Phosphate, Cytarabine, and Filgrastim in Treating Younger Patients With Relapsed or Refractory Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Adoptive Immunotherapy in Relapsed Hematological Malignancy: Early GVHD Prophylaxis
- Status
- COMPLETED
- Phase
- PHASE2
Accelerated v's Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours
- Status
- RECRUITING
- Phase
- PHASE3
A Phase II, Dose-finding Study of F-627 in Patients With Breast Cancer Receiving Myelotoxic Chemotherapy.
- Status
- COMPLETED
- Phase
- PHASE2
LEE011 (Ribociclib) in Combination With Docetaxel Plus Prednisone in mCRPC
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Ruxolitinib in Combination With Autotransplant
- Status
- WITHDRAWN
- Phase
- NA
Allogeneic Stem Cell Transplantation for Patients With Multiple Myeloma
- Status
- WITHDRAWN
- Phase
- EARLY_PHASE1
Epigenetic Reprogramming in Relapse AML
- Status
- TERMINATED
- Phase
- PHASE1
Talazoparib Plus Irinotecan With or Without Temozolomide in Children With Refractory or Recurrent Solid Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
HIV-Resistant Gene Modified Stem Cells and Chemotherapy in Treating Patients With Lymphoma With HIV Infection
- Status
- WITHDRAWN
- Phase
- PHASE1
Gene Therapy and Combination Chemotherapy in Treating Patients With AIDS-Related Non-Hodgkin Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Tissue and Hematopoietic/Mesenchymal Stem Cell for Humanized Xenograft Studies in Melanoma and Squamous Head and Neck Cancer
- Status
- COMPLETED
- Phase
- NA
Azacytidine Plus FLAG for Relapsed or Refractory AML
- Status
- UNKNOWN
- Phase
- PHASE2
Combination Therapy of Cord Blood and G-CSF for Patients With Brain Injury or Neurodegenerative Disorders
- Status
- COMPLETED
- Phase
- NA